Market Research Logo

Dialysis Devices Global Market - Forecast to 2022

Dialysis Devices Global Market - Forecast to 2022

The dialysis devices global market is expected to grow at a mid range single digit CAGR to reach $19,289 million by 2022. Dialysis is the treatment method for the patients with kidney failure, it replaces the function of kidneys by removing the wastes and excess fluid from the patient’s blood and thus the treatment helps to keep the patient body’s electrolytes such as sodium, potassium and chloride in balance.

Increasing number of ESRD patients & substantial healthcare expenditure on the treatment of end-stage renal disease (ESRD), growing number of patients suffering from diabetes and hypertension, rise in aging population, rising adoption of dialysis procedures over renal transplants, technological advancements and new product launches are driving the market growth.

Risk and complications associated with dialysis, product recalls, limited reimbursements for dialysis in developing countries, reimbursement cuts for dialysis in North America and stringent regulatory policies for the approval of new dialysis devices.

The dialysis devices global market by type is mainly segmented into hemodialysis and peritoneal dialysis. Hemodialysis market further segmented by products into machines and consumables, and by modalities into conventional long-term hemodialysis, short daily hemodialysis, and nocturnal hemodialysis. Hemodialysis machines sub-segmented into center-use hemodialysis machines and home-use hemodialysis machines whereas the hemodialysis consumables sub-segmented into dialyzers, access products, bloodlines, concentrates/dialysate, water treatment systems and other hemodialysis consumables. The dialyzers further segmented as cellulose-based and synthetic dialyzers based on material type, and high-flux and low-flux dialyzers based on flux type. Hemodialysis access products are further segmented as arteriovenous (AV) fistula, A-V Graft and central venous catheter (CVC). Hemodialysis water treatment systems mainly segmented as central water disinfection systems and portable water disinfection systems and these further segmented as chemical disinfection systems, heat disinfection systems and accessories individually. Peritoneal dialysis market segmented into peritoneal dialysis concentrate/dialysate, machines, catheters, transfer sets and others by-products, and continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) by modality.

The dialysis devices market by end-users is mainly segmented into In-Center dialysis and Home dialysis. The In-Centre dialysis further segmented into Hospital dialysis and Dialysis Centers whereas the Home dialysis is further segmented into Peritoneal Dialysis and Home Hemodialysis.

The dialysis devices global market by geography is divided into North America, Europe, Asia-Pacific and Rest of the World (RoW). Europe region commanded the largest market share. Increasing incidence of end-stage renal disease (ESRD), increasing hemodialysis facilities, increasing aging populations and increasing awareness of dialysis therapies are driving the European dialysis devices market growth. However, Asia-Pacific region is the fastest growing region due to growing number of ESRD patients, increasing healthcare expenditure, increasing awareness of healthcare, and refining healthcare infrastructure in the emerging countries, such as India and China.

Major players in dialysis devices global market include are Asahi Kasei Corp. (Japan), B. Braun Melsungen AG (Germany), Baxter International, Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), JMS Co. Ltd. (Japan), Kawasumi Laboratories (Japan), Nikkiso Co., Ltd. (Japan), Nipro Corporation (Japan), NxStage Medical Inc. (U.S.) and Toray Industries Inc. (Japan).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)


1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING THE MARKET
3.4 MARKET DYNAMICS
3.4.1 DRIVERS
3.4.1.1 Growing number of patients suffering from diabetes and hypertension
3.4.1.2 Rise in aging population
3.4.1.3 Increasing number of esrd patients and substantial healthcare cost on the treatment of end-stage renal disease.
3.4.1.4 Rising adoption of dialysis procedures over renal transplants
3.4.1.5 Technological advancements and new product launches.
3.4.2 RESTRAINTS
3.4.2.1 Risks and complications associated with dialysis
3.4.2.2 Product recalls
3.4.2.3 Limited reimbursements for dialysis in developing countries
3.4.2.4 Reimbursement cuts for dialysis in North America
3.4.2.5 Stringent regulatory policies for the approval of new dialysis products
3.4.3 OPPORTUNTIES
3.4.3.1 Emerging markets offer lucrative growth opportunities
3.4.3.2 Evolution of user - friendly and low cost dialysis products.
3.4.3.3 Increasing number of dialysis centers
3.4.3.4 Growing adoption of home hemodialysis treatment
3.4.4 CHALLENGES
3.4.4.1 Benefits of renal transplantation versus dialysis
3.4.4.2 Sustainability of players in the market
3.5 REGULATORY AFFAIRS
3.5.1 U.S.
3.5.2 EUROPE
3.5.3 CHINA
3.5.4 INDIA
3.5.5 JAPAN
3.6 PORTER’S FIVE FORCE ANALYSIS
3.6.1 THREAT OF NEW ENTRANTS
3.6.2 THREAT OF SUBSTITUTES
3.6.3 BARGAINING POWER OF SUPPLIERS
3.6.4 BARGAINING POWER OF BUYERS
3.6.5 RIVALRY AMONG EXISTING COMPETITORS
3.7 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.8 PATENT TRENDS
3.9 REIMBURSEMENT SCENARIO
3.10 CPT CODES
3.11 TECHNOLOGICAL ADVANCEMENTS
3.11.1 DIALYSIS MACHINES
3.11.2 DIALYZERS
3.11.3 WATER TREATMENT SYSTEMS
3.11.4 WEARABLE ARTIFICIAL KIDNEY
3.11.5 IMPLANTABLE ARTIFICIAL KIDNEY
3.12 UPCOMING TECHNOLOGIES
3.13 CLINICAL TRIALS
4 DIALYSIS DEVICES GLOBAL MARKET, BY TYPE
4.1 INTRODUCTION
4.2 HEMODIALYSIS MARKET
4.2.1 HEMODIALYSIS MARKET, BY PRODUCTS
4.2.1.1 Hemodialysis machines
4.2.1.1.1 Centre-use hemodialysis machines
4.2.1.1.2 Home-use hemodialysis machines
4.2.1.2 Hemodialysis consumables
4.2.1.2.1 Dialyzers
4.2.1.2.1.1 Dialyzers market, by material type
4.2.1.2.1.1.1 Cellulose based dialyzers
4.2.1.2.1.1.2 Synthetic dialyzers
4.2.1.2.1.2 Dialyzers market, by flux type
4.2.1.2.1.2.1 High – flux dialyzers
4.2.1.2.1.2.2 Low – flux dialyzers
4.2.1.2.2 Hemodialysis access products
4.2.1.2.2.1 Arteriovenous (AV) fistula
4.2.1.2.2.2 A-V graft
4.2.1.2.2.3 Central venous catheter (CVC)
4.2.1.2.3 Bloodlines
4.2.1.2.4 Hemodialysis concentrates/dialysate
4.2.1.2.5 Other hemodialysis consumables
4.2.1.2.5.1 Water treatment systems
4.2.1.2.5.1.1 Central water disinfection systems
4.2.1.2.5.1.1.1 Chemical disinfection systems
4.2.1.2.5.1.1.2 Heat disinfection systems
4.2.1.2.5.1.1.3 Accessories
4.2.1.2.5.1.2 Portable water disinfection systems
4.2.1.2.5.1.2.1 Chemical disinfection systems
4.2.1.2.5.1.2.2 Heat disinfection systems
4.2.1.2.5.1.2.3 Accessories
4.2.2 HEMODIALYSIS MARKET, BY MODALITY
4.2.2.1 Conventional long-term hemodialysis
4.2.2.2 Short daily hemodialysis
4.2.2.3 Nocturnal hemodialysis
4.3 PERITONEAL DIALYSIS
4.3.1 PERITONEAL DIALYSIS, BY PRODUCTS
4.3.1.1 Peritoneal dialysis machines
4.3.1.2 Peritoneal dialysis consumables
4.3.1.2.1 Peritoneal dialysis concentrate/dialysate
4.3.1.2.2 Peritoneal dialysis catheters
4.3.1.2.3 Peritoneal dialysis transfer sets
4.3.1.2.4 Other peritoneal dialysis products
4.3.2 PERITONEAL DIALYSIS MARKET, BY MODALITY
4.3.2.1 Continuous Ambulatory Peritoneal Dialysis (CAPD)
4.3.2.2 Automated Peritoneal Dialysis (APD)
5 DIALYSIS DEVICES GLOBAL MARKET, BY END-USERS
5.1 INTRODUCTION
5.2 IN-CENTRE DIALYSIS
5.2.1 HOSPITAL DIALYSIS
5.2.2 DIALYSIS CENTERS
5.3 HOME DIALYSIS
5.3.1 PERITONEAL DIALYSIS
5.3.2 HOME HEMODIALYSIS
6 DIALYSIS DEVICES GLOBAL MARKET, BY REGION
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.3 EUROPE
6.4 ASIA PACIFIC
6.5 REST OF THE WORLD
7 COMPANY DEVELOPMENTS
7.1 INTRODUCTION
7.2 AGREEMENTS & EXPANSIONS
7.3 MERGERS & ACQUISITIONS
7.4 APPROVALS
7.5 NEW PRODUCT LAUNCHES
8 MAJOR COMPANIES
8.1 ASAHI KASEI CORP.
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCT PORTFOLIO
8.1.4 KEY DEVELOPMENTS
8.1.5 BUSINESS STRATEGY
8.1.6 SWOT ANALYSIS
8.2 B. BRAUN MELSUNGEN AG
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCT PORTFOLIO
8.2.4 KEY DEVELOPMENTS
8.2.5 BUSINESS STRATEGY
8.2.6 SWOT ANALYSIS
8.3 BAXTER INTERNATIONAL, INC.
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCT PORTFOLIO
8.3.4 KEY DEVELOPMENTS
8.3.5 BUSINESS STRATEGY
8.3.6 SWOT ANALYSIS
8.4 FRESENIUS SE & CO. KGAA
8.4.1 OVERVIEW
8.4.2 FINANCIALS
8.4.3 PRODUCT PORTFOLIO
8.4.4 KEY DEVELOPMENTS
8.4.5 BUSINESS STRATEGY
8.4.6 SWOT ANALYSIS
8.5 JMS CO., LTD.
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCT PORTFOLIO
8.5.4 KEY DEVELOPMENTS
8.5.5 BUSINESS STRATEGY
8.5.6 SWOT ANALYSIS
8.6 KAWASUMI LABORATORIES, INC.
8.6.1 OVERVIEW
8.6.2 FINANCIALS
8.6.3 PRODUCT PORTFOLIO
8.6.4 KEY DEVELOPMENTS
8.6.5 BUSINESS STRATEGY
8.6.6 SWOT ANALYSIS
8.7 NIKKISO CO., LTD.
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCT PORTFOLIO
8.7.4 KEY DEVELOPMENTS
8.7.5 BUSINESS STRATEGY
8.7.6 SWOT ANALYSIS
8.8 NIPRO CORPORATION
8.8.1 OVERVIEW
8.8.2 FINANCIALS
8.8.3 PRODUCT PORTFOLIO
8.8.4 KEY DEVELOPMENTS
8.8.5 BUSINESS STRATEGY
8.8.6 SWOT ANALYSIS
8.9 NXSTAGE MEDICAL, INC.
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCT PORTFOLIO
8.9.4 KEY DEVELOPMENTS
8.9.5 BUSINESS STRATEGY
8.9.6 SWOT ANALYSIS
8.10 TORAY INDUSTRIES, INC.
8.10.1 OVERVIEW
8.10.2 FINANCIALS
8.10.3 PRODUCT PORTFOLIO
8.10.4 KEY DEVELOPMENTS
8.10.5 BUSINESS STRATEGY
8.10.6 SWOT ANALYSIS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report